These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23116405)

  • 1. Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia.
    Brousse V; Gandhi S; de Montalembert M; Height S; Dick MC; O'Driscoll S; Abihsera G; Rees DC
    Br J Haematol; 2013 Jan; 160(2):259-61. PubMed ID: 23116405
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
    Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
    Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia.
    Ware RE; Steinberg MH; Kinney TR
    Am J Hematol; 1995 Oct; 50(2):140-3. PubMed ID: 7572993
    [No Abstract]   [Full Text] [Related]  

  • 5. Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery.
    Schmugge M; Frischknecht H; Yonekawa Y; Baumgartner RW; Boltshauser E; Humbert J
    Blood; 2001 Apr; 97(7):2165-7. PubMed ID: 11264186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
    Lebensburger J; Johnson SM; Askenazi DJ; Rozario NL; Howard TH; Hilliard LM
    Am J Hematol; 2011 May; 86(5):430-2. PubMed ID: 21523807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry.
    Gilmore A; Cho G; Howard J; Layton M; Afif M; Hughes RG; Philpott NJ; Patankar S; Davies SC;
    Am J Hematol; 2011 Nov; 86(11):958-61. PubMed ID: 21948113
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.
    Guilliams KP; Fields ME; Dowling MM
    Stroke; 2019 Feb; 50(2):266-273. PubMed ID: 30661504
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of transfusion therapy in the treatment of sickle cell disease.
    Miller C
    J Intraven Nurs; 1994; 17(2):70-3. PubMed ID: 8064491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exchange transfusion in the management of CNS crisis in sickle cell disease.
    Jayabose S; Sheikh F; Mitra N
    Clin Pediatr (Phila); 1983 Nov; 22(11):776-7. PubMed ID: 6617059
    [No Abstract]   [Full Text] [Related]  

  • 12. Sickle cell disease and stroke.
    Adams RJ
    J Child Neurol; 1995 Mar; 10(2):75-6. PubMed ID: 7782612
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.
    Hall EM; Leonard J; Smith JL; Guilliams KP; Binkley M; Fallon RJ; Hulbert ML
    Pediatr Blood Cancer; 2016 Aug; 63(8):1431-7. PubMed ID: 27106860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-threatening complications of sickle cell disease in children.
    Mills ML
    JAMA; 1985 Sep; 254(11):1487-91. PubMed ID: 4032653
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.
    Nottage KA; Ware RE; Aygun B; Smeltzer M; Kang G; Moen J; Wang WC; Hankins JS; Helton KJ
    Br J Haematol; 2016 Oct; 175(2):331-338. PubMed ID: 27604981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic management of children with sickle cell anemia and cerebrovascular occlusive crisis.
    Seeler RA; Royal JE
    IMJ Ill Med J; 1977 Apr; 151(4):267-9. PubMed ID: 14909
    [No Abstract]   [Full Text] [Related]  

  • 17. [New issues in adult sickle sell disease].
    Girot R; Stankovic K; Lionnet F
    Bull Acad Natl Med; 2008 Oct; 192(7):1395-409; discussion 1409-11. PubMed ID: 19445365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease: time for a closer look at treatment options?
    Sheth S; Licursi M; Bhatia M
    Br J Haematol; 2013 Aug; 162(4):455-64. PubMed ID: 23772687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrovascular complications of sickle-cell anemia].
    Vernant JC; Delaporte JM; Buisson G; Bellance R; Bokor J; Loiseau P
    Rev Neurol (Paris); 1988; 144(8-9):465-73. PubMed ID: 3187303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia.
    Hayashi M; Calatroni A; Herzberg B; Ross AK; Rice HE; Thornburg C
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):487-90. PubMed ID: 21941139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.